Array BioPharma Company Profile (NASDAQ:ARRY)

Analyst Ratings

Consensus Ratings for Array BioPharma (NASDAQ:ARRY) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.25 (122.97% upside)

Analysts' Ratings History for Array BioPharma (NASDAQ:ARRY)
Show:
DateFirmActionRatingPrice TargetActions
6/20/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2016SunTrust Banks Inc.Initiated CoverageBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2016Piper Jaffray Cos.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Stifel NicolausLower Price TargetBuy$8.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2015JPMorgan Chase & Co.Boost Price TargetOverweight$8.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Array BioPharma (NASDAQ:ARRY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/1/2016        
5/3/2016Q316($0.12)($0.16)$30.35 million$43.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2016Q216($0.06)($0.17)$32.70 million$35.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q116($0.18)($0.15)$14.02 million$16.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2015Q415($0.16)($0.09)$10.29 million$12.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2015Q315($0.01)$0.37$6.00 million$6.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2015Q215($0.18)($0.06)$10.20 million$26.92 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q115($0.22)($0.21)$6.35 million$6.07 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014Q414($0.23)($0.22)$8.10 million$6.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014Q314($0.21)($0.20)$9.40 million$7.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014Q214($0.16)($0.13)$13.49 million$14.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2013Q114($0.18)($0.13)$11.20 million$14.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q4 2013($0.13)($0.06)$16.13 million$25.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2013Q3 2013($0.14)($0.19)$14.54 million$10.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2013Q2 2013($0.14)($0.10)$16.52 million$18.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2012Q113($0.15)($0.13)$16.70 million$15.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2012($0.11)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2012($0.16)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2012($0.12)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2011($0.25)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2011($0.28)($0.23)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Array BioPharma (NASDAQ:ARRY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.18)($0.15)($0.16)
Q2 20163($0.18)($0.14)($0.16)
Q4 20163($0.27)$0.09($0.13)
Q1 20171($0.20)($0.20)($0.20)
Q2 20171($0.21)($0.21)($0.21)
Q3 20171($0.24)($0.24)($0.24)
Q4 20171($0.16)($0.16)($0.16)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Array BioPharma (NASDAQ:ARRY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Array BioPharma (NASDAQ:ARRY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
1/20/2016Redmile Group, LlcMajor ShareholderBuy300,000$3.19$957,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2016Redmile Group, LlcMajor ShareholderBuy75,000$3.60$270,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2016Redmile Group, LlcMajor ShareholderBuy925,000$3.67$3,394,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2015Redmile Group, LlcMajor ShareholderBuy782,592$4.58$3,584,271.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2015Redmile Group, LlcMajor ShareholderBuy790,000$5.38$4,250,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/10/2015Redmile Group, LlcMajor ShareholderBuy1,048,993$5.80$6,084,159.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015Kyle LefkoffDirectorSell70,000$8.00$560,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Andrews R RobbinsSVPSell21,576$8.25$178,002.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Ron SquarerCEOSell40,000$8.25$330,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013Liam RatcliffeDirectorSell1,673,172$6.08$10,172,885.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/6/2013Liam RatcliffeDirectorSell577,286$5.79$3,342,485.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013John R MooreVPSell75,384$7.02$529,195.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2013John R MooreVPSell5,000$6.50$32,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Array BioPharma (NASDAQ:ARRY)
DateHeadline
07/25/16 03:07 PMArray BioPharma Inc. (NASDAQ:ARRY) Upcoming Earnings: What matter for investors? - The Voice Registrar
07/23/16 05:28 AMShares Stumbling of Late: Array BioPharma Inc. (NASDAQ:ARRY) - TGP
07/22/16 02:34 PMWill Array BioPharma Inc. (NASDAQ:ARRY) Surprise This Quarter? - Investor Newswire
07/22/16 10:47 AMArray BioPharma Inc. (NASDAQ:ARRY): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/21/16 08:10 PMEquity Roundup: Stock Performance Focus on Array BioPharma Inc. (NASDAQ:ARRY) - Press Telegraph
07/20/16 10:40 AMWill Array Biopharma Inc Short Squeeze Soon? - Consumer Eagle
07/20/16 10:40 AMEarnings Focus and Crowd Sourced Sentiment Review for Array BioPharma Inc. (NASDAQ:ARRY) - TGP
07/18/16 02:38 PMShare Performance Summary for: Array BioPharma Inc. (NASDAQ:ARRY) - Press Telegraph
07/18/16 02:38 PMStock's Trend Analysis Report: Array Biopharma Inc (NASDAQ:ARRY), Celgene Corporation (NASDAQ:CELG) - NYSE Journal (press release)
07/18/16 07:26 AMShares Moving Down on the Week: Array BioPharma Inc. (NASDAQ:ARRY) - Engelwood Daily
07/17/16 07:19 AMShares Experiencing a Downtrend: Array BioPharma Inc. (NASDAQ:ARRY) - TGP
07/16/16 02:34 PMImprimis Pharmaceuticals, (NASDAQ:IMMY) Increased 1.68%: Array BioPharma Inc. (NASDAQ:ARRY), Cross Country ... - KC Register
07/16/16 02:34 PMArray BioPharma Inc. (NASDAQ:ARRY) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/15/16 06:53 PMNew Broker Ratings For Array BioPharma Inc. (ARRY) - FTSE News
07/14/16 02:39 PMTrader's Buzzers: LaSalle Hotel Properties (LHO), Array BioPharma Inc. (ARRY), Tesoro Corporation (TSO) - iStreetWire
07/14/16 02:39 PMHot Biotech Stocks Recap: Array BioPharma Inc. (NASDAQ:ARRY), Anavex Life Sciences Corp. (NASDAQ:AVXL) - The Voice Registrar
07/14/16 02:39 PMRecent Price Moves of Shares: Alere Inc. (NYSE:ALR) , Array BioPharma Inc. (NASDAQ:ARRY) - Street Updates
07/14/16 02:39 PMArray BioPharma Inc Realized Volatility Hits Elevated Level - CML News
07/13/16 02:37 PMStocks Movement Analysis: ZIOPHARM Oncology (ZIOP), Array BioPharma (ARRY) - The Voice Registrar
07/13/16 10:42 AMHot Biotech Stocks Recap: Array BioPharma Inc. (NASDAQ:ARRY), ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) - The Voice Registrar
07/12/16 02:40 PMNoteworthy Analysts Suggestions: Orexigen Therapeutics, Inc. (NASDAQ:OREX) , Array BioPharma Inc. (NASDAQ ... - Street Updates
07/12/16 02:40 PMHC Stocks Buzzer: Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), Array Biopharma Inc (NASDAQ:ARRY) - share market updates (press release)
07/11/16 07:23 AMStock Rating Watch and Earnings Insight for Array BioPharma Inc. (NASDAQ:ARRY) - Press Telegraph
07/10/16 07:19 AMArray BioPharma Inc. (ARRY) Broker Price Targets For The Coming Week - Fiscal Standard
07/08/16 02:35 PMCan Array BioPharma Inc. (NASDAQ:ARRY) Improve on the Earnings Front? - Engelwood Daily
07/08/16 02:35 PMCompany Stock Focus for Array BioPharma Inc. (NASDAQ:ARRY): Which Way Will Shares Head? - Press Telegraph
07/08/16 02:35 PMArray BioPharma Inc. Stock Momentum at Critical Inflection Point - CML News
07/07/16 05:36 PMArray BioPharma To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference - [PR Newswire] - BOULDER, Colo., July 7, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cantor Fitzgerald 2 nd Annual Healthcare ...
07/07/16 02:34 PMArray BioPharma (ARRY) : Analyst Rating Update - Trade Calls
07/06/16 07:24 AMArray BioPharma Inc. (ARRY) Current Analyst Ratings - Fiscal Standard
07/05/16 02:35 PMHC Stocks Alerts: MannKind Corporation (NASDAQ:MNKD), Array Biopharma Inc (NASDAQ:ARRY) - share market updates (press release)
07/05/16 07:22 AMOverview of Analyst's Recommendations: Community Health Systems, Inc. (NYSE:CYH) , Array BioPharma Inc ... - Street Updates
07/04/16 07:26 AMBroker Outlook For The Week Ahead Array BioPharma Inc. (ARRY) - Fiscal Standard
07/02/16 10:17 AMSarissa Capital Management LP Increased Array Biopharma INC (NASDAQ:ARRY) by $4.35 Million as Shares Declined - Engelwood Daily
07/01/16 07:50 PMArray BioPharma Submits Binimetinib New Drug Application to U.S. FDA - KAIT Jonesboro, AR - Region 8 News, weather, sports
07/01/16 07:50 PMPre-Open Stock Movers 07/01: (ARRY) (NFLX) (WING) Higher; (MU) (FC) (ARNA) Lower (more...)
07/01/16 07:50 PMArray BioPharma Spikes On Announcement
07/01/16 02:37 PMHome Earnings Array BioPharma Inc. | $ARRY Stock | Shares Spike Up On Announcement... - TickerTV News (press release)
07/01/16 11:33 AMWhy These Stocks Are Trending on Friday -
07/01/16 10:37 AMArray BioPharma Inc. (NASDAQ:ARRY) Earnings Glance and Target Price Review - Engelwood Daily
07/01/16 10:37 AMArray BioPharma Inc. (NASDAQ:ARRY)submits NDA for binimetinib: The Joint Corp. (NASDAQ:JYNT), NeuroDerm Ltd ... - KC Register
07/01/16 07:37 AMWhy Array Is Making a Run -
06/30/16 08:01 PMAfter-Hours Stock Movers 06/30: (ARRY) (NFLX) (WING) Higher; (FC) (MU) (ARNA) (TSLA) Lower (more...)
06/30/16 03:03 PMARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
06/30/16 03:01 PM4:01 pm Array Biopharma submits NDA for binimetinib in patients with advanced NRAS-mutant melanoma to the FDA -
06/30/16 03:00 PMArray BioPharma Submits Binimetinib New Drug Application to U.S. FDA - [PR Newswire] - BOULDER, Colo., June 30, 2016 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) today announced the submission of a New Drug Application (NDA) for binimetinib in patients with advanced NRAS -mutant melanoma ...
06/30/16 10:27 AMAnalyst Rating Update on Array BioPharma (ARRY) - TheFounders Daily
06/29/16 07:43 PMCould Array Biopharma Inc See a Reversal After This Very Weak Session? - Engelwood Daily
06/29/16 10:47 AMArray BioPharma Inc. (NASDAQ:ARRY) Company Rating and Target Watch - Telanagana Press
06/28/16 07:13 AMArray BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : June 28, 2016 -

Social

About Array BioPharma

Array BioPharma logoArray BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer. The Company's wholly owned clinical stage drugs include Filanesib in Phase II clinical trials, is indicated for Kinesin spindle protein (KSP), inhibitor for MM; ARRY-797 in Phase II clinical trials, indicated for p38 inhibitor for Lamin A/C-related dilated cardiomyopathy (LMNA-DCM); ARRY-502 in Phase II clinical trials, indicated for CRTh2 antagonist for asthma, and ARRY-614 in Phase I clinical trials, is indicated for p38/Tie2 dual inhibitor for myelodysplastic syndromes (MDS). In addition, the Company has 11 ongoing partner-funded clinical programs, including two MEK inhibitors, which are both in Phase III clinical trials, binimetinib with Novartis and selumetinib with AstraZeneca.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: ARRY
  • CUSIP: 04269X10
Key Metrics:
  • Previous Close: $3.70
  • 50 Day Moving Average: $3.54
  • 200 Day Moving Average: $3.17
  • P/E Ratio: N/A
  • P/E Growth: -0.59
  • Market Cap: $530.72M
  • Beta: 2
  • Current Year EPS Consensus Estimate: $-0.63 EPS
  • Next Year EPS Consensus Estimate: $-0.57 EPS
Additional Links:
Array BioPharma (NASDAQ:ARRY) Chart for Wednesday, July, 27, 2016